• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

129 个经 BRCA1 和 BRCA2 基因突变检测的乳腺癌-卵巢癌家系的癌症患病率。

Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations.

机构信息

Cancer Genetics, Department of Genetics, University of Pretoria.

出版信息

S Afr Med J. 2010 Jan 29;100(2):113-7. doi: 10.7196/samj.3235.

DOI:10.7196/samj.3235
PMID:20459916
Abstract

BACKGROUND

Women who carry germline mutations in the breast-ovarian cancer susceptibility genes, BRCA1 and BRCA2, are at very high risk of developing breast and/or ovarian cancer. Both genes are tumour suppressor genes that protect all cells from deregulation, and there are reports of their involvement in other cancers that vary and seem to depend on the population investigated. It is therefore important to investigate the other associated cancers in different populations to assist with risk assessments.

OBJECTIVES

To assess the cancer risk profile in BRCA-mutation-positive and negative South African breast-ovarian cancer families, mainly of Caucasian origin.

DESIGN

Descriptive study in which the prevalence of all cancers in the pedigrees of BRCA1- and BRCA2-mutation-positive groups and a group of families without mutations in either gene were compared with the general population.

RESULTS

As expected, female breast and ovarian cancer was significantly increased in all three groups. Furthermore, male breast cancer was significantly elevated in the BRCA2-positive and BRCA-negative groups. Stomach cancer prevalence was significantly elevated in the BRCA2-positive families compared with the general population.

CONCLUSIONS

These results can be applied in estimation of cancer risks and may contribute to more comprehensive counselling of mutation-positive Caucasian breast and/or ovarian cancer families.

摘要

背景

携带乳腺癌-卵巢癌易感基因 BRCA1 和 BRCA2 种系突变的女性,罹患乳腺癌和/或卵巢癌的风险极高。这两个基因都是肿瘤抑制基因,能保护所有细胞免受失调的影响,有报道称它们还与其他癌症有关,且似乎取决于所研究的人群。因此,有必要在不同人群中研究其他相关癌症,以协助进行风险评估。

目的

评估 BRCA 基因突变阳性和阴性的南非乳腺癌-卵巢癌家系的癌症风险特征,这些家系主要来自白种人群。

设计

描述性研究,将 BRCA1-和 BRCA2-基因突变阳性组及一组两个基因均未发生突变的家系的所有癌症患病率与普通人群进行比较。

结果

正如预期的那样,三组人群中女性乳腺癌和卵巢癌的发病率显著升高。此外,BRCA2 阳性组和 BRCA 阴性组男性乳腺癌的发病率也显著升高。BRCA2 阳性家系的胃癌患病率明显高于普通人群。

结论

这些结果可用于癌症风险的估计,并有助于对 BRCA 基因突变阳性的白种人乳腺癌和/或卵巢癌家系进行更全面的咨询。

相似文献

1
Cancer prevalence in 129 breast-ovarian cancer families tested for BRCA1 and BRCA2 mutations.129 个经 BRCA1 和 BRCA2 基因突变检测的乳腺癌-卵巢癌家系的癌症患病率。
S Afr Med J. 2010 Jan 29;100(2):113-7. doi: 10.7196/samj.3235.
2
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.对不同种族高危女性群体进行的基因检测:对欧洲和非洲裔美国家庭中BRCA1和BRCA2基因突变的比较分析。
JAMA. 2005 Oct 19;294(15):1925-33. doi: 10.1001/jama.294.15.1925.
3
BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation.印度南部女性中BRCA1和BRCA2基因种系突变分析:鉴定出四个新突变以及185delAG突变的高频率发生
J Biosci. 2009 Sep;34(3):415-22. doi: 10.1007/s12038-009-0048-9.
4
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.意大利乳腺癌和/或卵巢癌家族中新型BRCA1和BRCA2种系突变以及突变谱和患病率评估
Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.
5
Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.癌症患者亲属中患乳腺癌和卵巢癌的情况,有无BRCA突变。
Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):359-63. doi: 10.1158/1055-9965.EPI-05-0687.
6
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.在未根据家族史进行选择的病例系列中检测到的与BRCA1或BRCA2基因突变相关的乳腺癌和卵巢癌平均风险:22项研究的综合分析
Am J Hum Genet. 2003 May;72(5):1117-30. doi: 10.1086/375033. Epub 2003 Apr 3.
7
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.比利时乳腺癌/卵巢癌家族中BRCA1和BRCA2种系突变谱及频率
Br J Cancer. 2004 Mar 22;90(6):1244-51. doi: 10.1038/sj.bjc.6601656.
8
Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both.乳腺癌、卵巢癌或两者皆有的家族后代中,BRCA1突变与后代出生时的男女性别比例之间的关联。
JAMA. 2003 Aug 20;290(7):929-31. doi: 10.1001/jama.290.7.929.
9
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.来自一家乳腺癌风险评估诊所的乳腺-卵巢癌家族中BRCA1和BRCA2的种系突变。
J Clin Oncol. 2001 Apr 15;19(8):2247-53. doi: 10.1200/JCO.2001.19.8.2247.
10
Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.8005 名有乳腺癌家族史的女性中卵巢癌发病情况:BRCA1 和 BRCA2 检测阴性的家族中浸润性卵巢癌发病风险无增加。
J Med Genet. 2013 Jun;50(6):368-72. doi: 10.1136/jmedgenet-2013-101607. Epub 2013 Mar 28.

引用本文的文献

1
Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.CXCL1在生殖系统癌症(乳腺癌、宫颈癌、子宫内膜癌、卵巢癌和前列腺癌)发生中的作用及临床意义
Int J Mol Sci. 2023 Apr 14;24(8):7262. doi: 10.3390/ijms24087262.
2
Gastric Cancer Risk and Pathogenesis in and Carriers.[基因名称]携带者的胃癌风险与发病机制
Cancers (Basel). 2022 Dec 1;14(23):5953. doi: 10.3390/cancers14235953.
3
Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis.
男性乳腺癌幸存者中第二原发性癌症的发病风险:系统评价和荟萃分析。
Br J Cancer. 2022 Nov;127(9):1660-1669. doi: 10.1038/s41416-022-01940-1. Epub 2022 Sep 17.
4
Prevalence of Clinically Relevant Germline Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience.南非一个未经过筛选的大型乳腺癌和卵巢癌队列中临床相关种系变异的患病率:公共部门的经验
Front Genet. 2022 Apr 8;13:834265. doi: 10.3389/fgene.2022.834265. eCollection 2022.
5
Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies.基因与相关癌症:来自流行病学队列研究的荟萃分析。
Medicina (Kaunas). 2021 Aug 30;57(9):905. doi: 10.3390/medicina57090905.
6
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?BRCA基因突变与胃肠道癌症:何时会出现意外情况?
World J Clin Oncol. 2021 Jul 24;12(7):565-580. doi: 10.5306/wjco.v12.i7.565.
7
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.在不同南非种族群体中,患有绝经前和/或三阴性乳腺癌的个体的BRCA1、BRCA2和PALB2基因突变以及CHEK2基因c.1100delC突变
BMC Cancer. 2015 Nov 17;15:912. doi: 10.1186/s12885-015-1913-6.
8
The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers.BRCA1和BRCA2突变在前列腺癌、胰腺癌和胃癌中的作用。
Hered Cancer Clin Pract. 2015 Aug 1;13(1):16. doi: 10.1186/s13053-015-0038-x. eCollection 2015.